Market Overview:
The global assisted reproductive technology drugs treatment market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as rising infertility rates, technological advancements in the field of assisted reproductive technology (ART), and increasing demand for fertility treatments. The global assisted reproductive technology drugs treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into Gnrh agonists, Gnrh antagonists, gonadotropins, human chorionic gonadotropins (hCG), and others. Gonadotropins are further sub-segmented into follicle-stimulating hormone (FSH) analogs and luteinizing hormone (LH) analogs. On the basis of application, hospitals pharmacies accounted for a major share of the global assisted reproductive technology drugs treatment market in 2017 owing to increased use of ART procedures in hospitals settings across regions such as North America and Europe.
Product Definition:
Assisted reproductive technology drugs treatment is the use of medications to help couples conceive a child. The medications can help improve the chances of success for fertility treatments such as in vitro fertilization (IVF).
Gnrh Agonists:
Gnrh agonists is a class of drugs that act to reduce the level of FSH (follicle-stimulating hormone) and LH (luteinizing hormone), two hormones essential for ovulation. By acting as anti-agonistic agents, these drugs inhibit the release of both ovarian and testicular testosterone in men as well as women. GnRH agonist treatment helps restore hormonal balance in patients suffering from Polycystic Ovary Syndrome (PCOS).
Gnrh Antagonists:
Gnrh antagonists are used in ART procedures to prevent the release of gonadotropins from the pituitary gland. They have a dual action mechanism of action, firstly they inhibit Luteinizing Hormone Releasing Hormone (LHRH) and secondly they block secretion of Follicle Stimulating hormone (FSH).
Application Insights:
Based on application, the market is segmented into hospitals, pharmacies and other retail pharmacies, online pharmacies and others. Hospitals held the largest share in 2017 owing to factors such as a large number of patients undergoing assisted reproductive technology drugs treatment procedures at any given time. Furthermore, hospitals are considered centers of excellence in assisted reproductive technology due to advanced medical care provided by them along with a high success rate associated with these treatments.
Pharmacies accounted for the second-largest share in terms of revenue due to increasing adoption of Assisted Reproductive Technology (ART) drugs across various regions coupled with rising awareness about these services among general public pharmacists. The growing trend towards self-referral has been driving growth for many pharma stores that offer free consultation before purchasing expensive medicines as compared to supermarkets or local drugstores where one has to pay even if he/she does not buy anything else.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the increasing infertility rate, rising awareness about available treatment options, and availability of highly skilled physicians in this region. Moreover, high adoption of Assisted Reproduction Technology (ART) procedures has resulted in higher number of patients suffering from male factor infertility. The presence of well-developed healthcare infrastructure and favorable reimbursement policies are some other factors contributing toward regional growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to a large population base with unmet needs for fertility treatment and growing awareness about various assisted reproductive technologies among men as well as women population groups thereby boosting demand for ART services across this region.
Growth Factors:
- Increasing incidence of infertility: The increasing incidence of infertility is one of the key growth drivers for the assisted reproductive technology drugs treatment market. According to a study by the World Health Organization, around 10%–15% couples across the world are affected by infertility. This number is expected to rise in future due to various factors such as changing lifestyle and increasing stress levels.
- Rising demand for fertility treatments: The rising demand for fertility treatments is another major growth driver for the assisted reproductive technology drugs treatment market. Fertility treatments are becoming increasingly popular due to their ability to help couples conceive a child naturally, even in cases where traditional methods have failed. This has led to an increase in adoption rates of these treatments, thereby driving market growth.
- Technological advancements: The rapid technological advancements taking place in the field of assisted reproductive technology (ART) are another key factor fuelling market growth. These advancements have resulted in introduction of new and innovative ART procedures, which are helping more couples conceive children than ever before .This is further propelling demand for ART drugs and driving market expansion..
Scope Of The Report
Report Attributes
Report Details
Report Title
Assisted Reproductive Technology Drugs Treatment Market Research Report
By Type
Gnrh Agonists, Gnrh Antagonists, Gonadotropins, Human Chorionic Gonadotropins, Others
By Application
Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
AbbVie Inc., Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Sun Pharma, Abbott, Irvine Scientific, Origio a/s, Vitro Life, Esco Micro Pte. Ltd., IVFtech ApS, Research Instruments, Genea Limited, Smiths Medical, Cook Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Assisted Reproductive Technology Drugs Treatment Market Report Segments:
The global Assisted Reproductive Technology Drugs Treatment market is segmented on the basis of:
Types
Gnrh Agonists, Gnrh Antagonists, Gonadotropins, Human Chorionic Gonadotropins, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie Inc.
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Sun Pharma
- Abbott
- Irvine Scientific
- Origio a/s
- Vitro Life
- Esco Micro Pte. Ltd.
- IVFtech ApS
- Research Instruments
- Genea Limited
- Smiths Medical
- Cook Medical
Highlights of The Assisted Reproductive Technology Drugs Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gnrh Agonists
- Gnrh Antagonists
- Gonadotropins
- Human Chorionic Gonadotropins
- Others
- By Application:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Assisted Reproductive Technology Drugs Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Assisted reproductive technology drugs treatment is the use of medications to help a woman conceive or to improve her chances of becoming pregnant. These medications can be used in combination with other fertility treatments, such as intrauterine insemination (IUI) or artificial insemination (AI).
Some of the major players in the assisted reproductive technology drugs treatment market are AbbVie Inc., Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Sun Pharma, Abbott, Irvine Scientific, Origio a/s, Vitro Life, Esco Micro Pte. Ltd., IVFtech ApS, Research Instruments, Genea Limited, Smiths Medical, Cook Medical.
The assisted reproductive technology drugs treatment market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Assisted Reproductive Technology Drugs Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Assisted Reproductive Technology Drugs Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Assisted Reproductive Technology Drugs Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Assisted Reproductive Technology Drugs Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Assisted Reproductive Technology Drugs Treatment Market Size & Forecast, 2018-2028
4.5.1 Assisted Reproductive Technology Drugs Treatment Market Size and Y-o-Y Growth
4.5.2 Assisted Reproductive Technology Drugs Treatment Market Absolute $ Opportunity
Chapter 5 Global Assisted Reproductive Technology Drugs Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Type
5.2.1 Gnrh Agonists
5.2.2 Gnrh Antagonists
5.2.3 Gonadotropins
5.2.4 Human Chorionic Gonadotropins
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Assisted Reproductive Technology Drugs Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Applications
6.2.1 Hospitals Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Assisted Reproductive Technology Drugs Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Assisted Reproductive Technology Drugs Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Type
9.6.1 Gnrh Agonists
9.6.2 Gnrh Antagonists
9.6.3 Gonadotropins
9.6.4 Human Chorionic Gonadotropins
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Applications
9.10.1 Hospitals Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Assisted Reproductive Technology Drugs Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Type
10.6.1 Gnrh Agonists
10.6.2 Gnrh Antagonists
10.6.3 Gonadotropins
10.6.4 Human Chorionic Gonadotropins
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Applications
10.10.1 Hospitals Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Assisted Reproductive Technology Drugs Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Type
11.6.1 Gnrh Agonists
11.6.2 Gnrh Antagonists
11.6.3 Gonadotropins
11.6.4 Human Chorionic Gonadotropins
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Applications
11.10.1 Hospitals Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Assisted Reproductive Technology Drugs Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Type
12.6.1 Gnrh Agonists
12.6.2 Gnrh Antagonists
12.6.3 Gonadotropins
12.6.4 Human Chorionic Gonadotropins
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Applications
12.10.1 Hospitals Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Assisted Reproductive Technology Drugs Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Type
13.6.1 Gnrh Agonists
13.6.2 Gnrh Antagonists
13.6.3 Gonadotropins
13.6.4 Human Chorionic Gonadotropins
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Assisted Reproductive Technology Drugs Treatment Market Size Forecast by Applications
13.10.1 Hospitals Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Assisted Reproductive Technology Drugs Treatment Market: Competitive Dashboard
14.2 Global Assisted Reproductive Technology Drugs Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie Inc.
14.3.2 Pfizer Inc.
14.3.3 Sanofi
14.3.4 Teva Pharmaceutical Industries Ltd.
14.3.5 Merck & Co., Inc.
14.3.6 Sun Pharma
14.3.7 Abbott
14.3.8 Irvine Scientific
14.3.9 Origio a/s
14.3.10 Vitro Life
14.3.11 Esco Micro Pte. Ltd.
14.3.12 IVFtech ApS
14.3.13 Research Instruments
14.3.14 Genea Limited
14.3.15 Smiths Medical
14.3.16 Cook Medical
